Search research articles
Contact Us
Filters
Showing results (71-80 of 89) with videos related to
Page
of 9
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
April 1, 2021
T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severity
Rebecca Elyanow, Thomas M Snyder, Sudeb C Dalai, et al.
Cancer
|
December 8, 2016
Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study
Kelly G Paulson, Christopher W Lewis, Mary W Redman, et al.
The Journal of Nutrition
|
March 21, 2014
Biomarkers of one-carbon metabolism are associated with biomarkers of inflammation in women
Clare Abbenhardt, Joshua W Miller, Xiaoling Song, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 6, 2026
Cohort Profile Update: Survey of Health, Ageing and Retirement in Europe: Biomarker data for age-related health conditions
Martina Boersch-Supan, Axel Boersch-Supan, Karen Andersen-Ranberg, et al.
Blood
|
August 15, 2002
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes
Peter A McSweeney, Richard A Nash, Keith M Sullivan, et al.
Biorxiv : the Preprint Server for Biology
|
June 30, 2021
Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system
Jason Z Zhang, Hsien-Wei Yeh, Alexandra C Walls, et al.
JCI Insight
|
April 19, 2022
T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity
Rebecca Elyanow, Thomas M Snyder, Sudeb C Dalai, et al.
Blood
|
April 25, 2007
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study
Richard A Nash, Peter A McSweeney, Leslie J Crofford, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 14, 2020
Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 after COVID-19
Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, et al.
The Journal of Infectious Diseases
|
February 12, 2022
Detection and Kinetics of Subgenomic Severe Acute Respiratory Syndrome Coronavirus 2 RNA Viral Load in Longitudinal Diagnostic RNA-Positive Samples
Meagan E Deming, Tracy Q Dong, Vaidehi Agrawal, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 89) with videos related to
Sort By:
Page
of 9
Medrxiv : the Preprint Server for Health Sciences
|
April 1, 2021
T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severity
Rebecca Elyanow, Thomas M Snyder, Sudeb C Dalai, et al.
Cancer
|
December 8, 2016
Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study
Kelly G Paulson, Christopher W Lewis, Mary W Redman, et al.
The Journal of Nutrition
|
March 21, 2014
Biomarkers of one-carbon metabolism are associated with biomarkers of inflammation in women
Clare Abbenhardt, Joshua W Miller, Xiaoling Song, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 6, 2026
Cohort Profile Update: Survey of Health, Ageing and Retirement in Europe: Biomarker data for age-related health conditions
Martina Boersch-Supan, Axel Boersch-Supan, Karen Andersen-Ranberg, et al.
Blood
|
August 15, 2002
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes
Peter A McSweeney, Richard A Nash, Keith M Sullivan, et al.
Biorxiv : the Preprint Server for Biology
|
June 30, 2021
Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system
Jason Z Zhang, Hsien-Wei Yeh, Alexandra C Walls, et al.
JCI Insight
|
April 19, 2022
T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity
Rebecca Elyanow, Thomas M Snyder, Sudeb C Dalai, et al.
Blood
|
April 25, 2007
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study
Richard A Nash, Peter A McSweeney, Leslie J Crofford, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 14, 2020
Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 after COVID-19
Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, et al.
The Journal of Infectious Diseases
|
February 12, 2022
Detection and Kinetics of Subgenomic Severe Acute Respiratory Syndrome Coronavirus 2 RNA Viral Load in Longitudinal Diagnostic RNA-Positive Samples
Meagan E Deming, Tracy Q Dong, Vaidehi Agrawal, et al.
Page
of 9